Skip to main content
. 2021 Sep 30;12:726215. doi: 10.3389/fimmu.2021.726215

Figure 1.

Figure 1

Death-censored graft survival in patients with/without histological recurrence of IgAN in (A) total cohort (log rank p value p < 0.0001) and (B) only in recipients who received their first graft (log rank p value p < 0.0001).